ICI set to approve splitting of group
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.IMPERIAL Chemical Industries is expected to give the go- ahead this week to radical plans to split the group into two separately quoted companies - one comprising Zeneca, the group's pharmaceuticals andagrichemical interests, and the other the bulk chemical interests.
At the same time, it will announce proposals for Zeneca to raise up to pounds 1bn of new equity, either through an international offer of new shares or a rights issue.
The plans have caused controversy in the City, with some merchant bankers and stockbrokers arguing that there would be no need for ICI to raise new money if it remained a single company.
To some extent this is being reflected at board level within ICI, where several directors have been expressing reservations about what amounts to the most dramatic shake-up since the company was formed in the 1920s.
Well-placed sources denied rumours of a boardroom split over the issue but conceded there had been 'a lively debate'.
Sir Denys Henderson, the chairman, has kept non-executives informed as the plans developed and believes unanimity has now been achieved.
The decision is due to be taken formally at a board meeting on Wednesday and announced the following day with the group's full-year figures.
Fears in the stock market that the group will immediately announce a pounds 1bn conventional rights issue to accompany the figures appear misplaced.
ICI said when it first announced the plans in July that consideration would be given to Zeneca raising the new money - not ICI as a whole - and this still seems to be the favoured route.
However, Sir Denys is believed to be keen for existing ICI shareholders to be given preferential treatment in any offering of new Zeneca shares.
Financial advisers have tended to favour the different route of an international offer of new shares.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments